Company: CNTB
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001835268-25-000058
Chunk: 94

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 3
Chunk 94
---
 as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

29

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Connect Biopharma Holdings LimitedDate: November 12, 2025/s/ Barry D. QuartBarry D. Quart, Pharm.D.Chief Executive Officer(Registrant’s Principal Executive Officer)/s/ Lisa PerazaLisa PerazaSenior Vice President of Finance(Registrant’s Principal Financial and Accounting Officer)

30